GPR55 and Alzheimer disease: Recently, by using a GPR55 agonist, O-1602, Xiang and colleagues showed attenuation in cognitive impairment, neurotoxicity neuroinflammation, and synaptic dysfunction in a mouse model of AD induced by Aβ42 and streptozotocin [47,48].